BAYHILL THERAPEUTICS

Lawrence Steinman, M.D. co-founded Bayhill in 2001 and has served as Chairman of our Scientific Advisory Board and member of our board of directors since inception. Since 1980, Dr. Steinman has been on the faculty at Stanford University, where he is Professor of Neurological Sciences, Neurology and Pediatrics and Chairman of the Interdepartmental Program in Immunology. From 1988 to 1998, he served on the board of directors of Centocor, Inc., which was acquired by Johnson and Johnson in 1998. Dr. Steinman’s clinical achievements include the development of two antigen-specific therapies that use DNA vaccines for multiple sclerosis and type 1 diabetes. He has received various awards for his scientific contributions, including the John M. Dystel Prize from the American Academy of Neurology and the National MS Society for his multiple sclerosis research. He was also twice awarded a Javits Neuroscience Award by the U.S. Congress and the National Institutes of Health (NIH). Dr. Steinman received a B.A. from Dartmouth College and an M.D. from Harvard University.

Hideki Garren, M.D., Ph.D. co-founded Bayhill in 2001 and has served as our Vice President of Research since 2005, and prior to that served as our Director of Research from 2001 to 2005. Since 2003, Dr. Garren has been a member of the adjunct clinical faculty in the Department of Neurology at Stanford University School of Medicine. Dr. Garren received a B.S. from the California Institute of Technology, a Ph.D. in Molecular Biology from the University of California, Los Angeles, Molecular Biology Institute, and an M.D. from the University of California, Los Angeles, School of Medicine.

William H. Robinson, M.D., Ph.D. co-founded Bayhill in 2001 and currently serves as a consultant to the Company. Dr. Robinson is an Assistant Professor of Medicine in the Division of Immunology and Rheumatology at Stanford University, where his research is focused on developing novel therapeutics for multiple sclerosis and rheumatoid arthritis. He received his undergraduate, graduate and medical degrees from Stanford University, and completed residency training in internal medicine at the University of California, San Francisco.

Paul J. (P. J.) Utz, M.D. co-founded Bayhill in 2001 and currently serves as a consultant to the Company. Since 1999, Dr. Utz has been an Assistant Professor of Medicine in the Division of Rheumatology and Immunology at StanfordUniversity, and served as Acting Chief of the Division in 2007. He is Director of the Center for Clinical Immunology at Stanford (CCIS) and Secretary/Treasurer of the Federation of Clinical Immunology Societies (FoCIS).. In 1996, Dr. Utz joined the Harvard Medical School faculty after completing his Internal Medicine residency, Rheumatology fellowship, and post-doctoral training at Brigham and Women’s Hospital in Boston. In 1991, he received his M.D. from Stanford, where he codiscovered the Nuclear Factor of Activated T Cells (NFAT) transcription factor with J.P. Shaw in Dr. Gerald Crabtree’s laboratory. In 1986, Dr. Utz earned his Bachelor’s degree from King’s College in Wilkes-Barre, PA.. In addition to being a co-founder of Bayhil, Dr. Utz is a member of the Scientific Advisory Boards of XDx. Inc. and Monogram Biosciences, Inc.